CAS
60731-46-6
AA-Sequence
H-DL-Ser(1)-DL-Asn-DL-Leu-DL-Ser-DL-xiThr-DL-Asu(1)-DL-Val-DL-Leu-Gly-DL-Lys-DL-Leu-DL-Ser-DL-Gln-DL-Glu-DL-Leu-DL-His-DL-Lys-DL-Leu-DL-Gln-DL-xiThr-DL-Tyr-DL-Pro-DL-Arg-DL-xiThr-DL-Asp-DL-Val-Gly-DL-Ala-Gly-DL-xiThr-DL-Pro-NH2
Originator
Asahi Kasei Pharma Corp
First marketed by
Asahi Kasei Pharma Corp
Name of FDF
Elcitonin®
Original FDF
RTU solution for subcutaneous or intramuscular injection
Mode of Action
Calcitonin derivative used as an anti-parathyroid agent for remitting or eliminating pain caused by osteoporosis (Endocrinology, Musculoskeletal).
Indications
Anti-parathyroid agent for remitting or eliminating pain caused by osteoporosis.
Patent status
Generic products are available